Search

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

4.7 (561) · $ 8.99 · In stock

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

PDF) Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to

PDF) Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to

Frontiers  Vaccine-associated enhanced disease in humans and

Frontiers Vaccine-associated enhanced disease in humans and

PDF) Reduced immunogenicity of a live Salmonella enterica serovar

PDF) Reduced immunogenicity of a live Salmonella enterica serovar

The Role of Vaccines in Combating Antimicrobial Resistance

The Role of Vaccines in Combating Antimicrobial Resistance

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant

Controlled Human Infection Models To Accelerate Vaccine

Controlled Human Infection Models To Accelerate Vaccine

Vaccines, Free Full-Text

Vaccines, Free Full-Text

Intestinal helminth infection impairs oral and parenteral vaccine

Intestinal helminth infection impairs oral and parenteral vaccine

Vaccines platforms and COVID-19: what you need to know

Vaccines platforms and COVID-19: what you need to know

Bioengineering, Free Full-Text

Bioengineering, Free Full-Text